The NCCN. Invasive breast cancer: Clinical practice guidelines in oncology™

Robert W. Carlson, Benjamin O. Anderson, Harold J. Burstein, W. Bradford Carter, Stephen B. Edge, William B. Farrar, Lori J. Goldstein, William J. Gradishar, Daniel F. Hayes, Clifford A. Hudis, Mohammad Jahanzeb, Britt Marie Ljung, Krystyna Kiel, Lawrence B. Marks, Beryl McCormick, Lisle M. Nabell, Lori J. Pierce, Elizabeth C. Reed, Samuel M. Silver, Mary Lou SmithGeorge Somlo, Richard L. Theriault, John H. Ward, Eric P. Winer, Antonio C. Wolff

Research output: Contribution to journalReview article

53 Citations (Scopus)

Abstract

The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician are responsible for jointly exploring and selecting the most appropriate option from among the available alternatives. With rare exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, not a single clinical situation exists in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient and physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment but also contribute to improving the treatment of future patients.

Original languageEnglish (US)
Pages (from-to)246-312
Number of pages67
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume5
Issue number3
StatePublished - Mar 1 2007

Fingerprint

Practice Guidelines
Breast Neoplasms
Clinical Trials
Physicians
Therapeutics
Patient Participation
Guidelines
Neoplasms

Keywords

  • Adjuvant therapy
  • Breast cancer
  • Breast-conserving therapy
  • Chemotherapy
  • Ductal carcinoma in situ
  • Endocrine therapy
  • Lobular carcinoma in situ
  • Mastectomy
  • NCCN Clinical Practice Guidelines
  • Radiation
  • Therapy

ASJC Scopus subject areas

  • Oncology

Cite this

Carlson, R. W., Anderson, B. O., Burstein, H. J., Carter, W. B., Edge, S. B., Farrar, W. B., ... Wolff, A. C. (2007). The NCCN. Invasive breast cancer: Clinical practice guidelines in oncology™. JNCCN Journal of the National Comprehensive Cancer Network, 5(3), 246-312.

The NCCN. Invasive breast cancer : Clinical practice guidelines in oncology™. / Carlson, Robert W.; Anderson, Benjamin O.; Burstein, Harold J.; Carter, W. Bradford; Edge, Stephen B.; Farrar, William B.; Goldstein, Lori J.; Gradishar, William J.; Hayes, Daniel F.; Hudis, Clifford A.; Jahanzeb, Mohammad; Ljung, Britt Marie; Kiel, Krystyna; Marks, Lawrence B.; McCormick, Beryl; Nabell, Lisle M.; Pierce, Lori J.; Reed, Elizabeth C.; Silver, Samuel M.; Smith, Mary Lou; Somlo, George; Theriault, Richard L.; Ward, John H.; Winer, Eric P.; Wolff, Antonio C.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 5, No. 3, 01.03.2007, p. 246-312.

Research output: Contribution to journalReview article

Carlson, RW, Anderson, BO, Burstein, HJ, Carter, WB, Edge, SB, Farrar, WB, Goldstein, LJ, Gradishar, WJ, Hayes, DF, Hudis, CA, Jahanzeb, M, Ljung, BM, Kiel, K, Marks, LB, McCormick, B, Nabell, LM, Pierce, LJ, Reed, EC, Silver, SM, Smith, ML, Somlo, G, Theriault, RL, Ward, JH, Winer, EP & Wolff, AC 2007, 'The NCCN. Invasive breast cancer: Clinical practice guidelines in oncology™', JNCCN Journal of the National Comprehensive Cancer Network, vol. 5, no. 3, pp. 246-312.
Carlson RW, Anderson BO, Burstein HJ, Carter WB, Edge SB, Farrar WB et al. The NCCN. Invasive breast cancer: Clinical practice guidelines in oncology™. JNCCN Journal of the National Comprehensive Cancer Network. 2007 Mar 1;5(3):246-312.
Carlson, Robert W. ; Anderson, Benjamin O. ; Burstein, Harold J. ; Carter, W. Bradford ; Edge, Stephen B. ; Farrar, William B. ; Goldstein, Lori J. ; Gradishar, William J. ; Hayes, Daniel F. ; Hudis, Clifford A. ; Jahanzeb, Mohammad ; Ljung, Britt Marie ; Kiel, Krystyna ; Marks, Lawrence B. ; McCormick, Beryl ; Nabell, Lisle M. ; Pierce, Lori J. ; Reed, Elizabeth C. ; Silver, Samuel M. ; Smith, Mary Lou ; Somlo, George ; Theriault, Richard L. ; Ward, John H. ; Winer, Eric P. ; Wolff, Antonio C. / The NCCN. Invasive breast cancer : Clinical practice guidelines in oncology™. In: JNCCN Journal of the National Comprehensive Cancer Network. 2007 ; Vol. 5, No. 3. pp. 246-312.
@article{8a9e6423f25c4534aa0ed1499b6cba99,
title = "The NCCN. Invasive breast cancer: Clinical practice guidelines in oncology™",
abstract = "The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician are responsible for jointly exploring and selecting the most appropriate option from among the available alternatives. With rare exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, not a single clinical situation exists in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient and physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment but also contribute to improving the treatment of future patients.",
keywords = "Adjuvant therapy, Breast cancer, Breast-conserving therapy, Chemotherapy, Ductal carcinoma in situ, Endocrine therapy, Lobular carcinoma in situ, Mastectomy, NCCN Clinical Practice Guidelines, Radiation, Therapy",
author = "Carlson, {Robert W.} and Anderson, {Benjamin O.} and Burstein, {Harold J.} and Carter, {W. Bradford} and Edge, {Stephen B.} and Farrar, {William B.} and Goldstein, {Lori J.} and Gradishar, {William J.} and Hayes, {Daniel F.} and Hudis, {Clifford A.} and Mohammad Jahanzeb and Ljung, {Britt Marie} and Krystyna Kiel and Marks, {Lawrence B.} and Beryl McCormick and Nabell, {Lisle M.} and Pierce, {Lori J.} and Reed, {Elizabeth C.} and Silver, {Samuel M.} and Smith, {Mary Lou} and George Somlo and Theriault, {Richard L.} and Ward, {John H.} and Winer, {Eric P.} and Wolff, {Antonio C.}",
year = "2007",
month = "3",
day = "1",
language = "English (US)",
volume = "5",
pages = "246--312",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "3",

}

TY - JOUR

T1 - The NCCN. Invasive breast cancer

T2 - Clinical practice guidelines in oncology™

AU - Carlson, Robert W.

AU - Anderson, Benjamin O.

AU - Burstein, Harold J.

AU - Carter, W. Bradford

AU - Edge, Stephen B.

AU - Farrar, William B.

AU - Goldstein, Lori J.

AU - Gradishar, William J.

AU - Hayes, Daniel F.

AU - Hudis, Clifford A.

AU - Jahanzeb, Mohammad

AU - Ljung, Britt Marie

AU - Kiel, Krystyna

AU - Marks, Lawrence B.

AU - McCormick, Beryl

AU - Nabell, Lisle M.

AU - Pierce, Lori J.

AU - Reed, Elizabeth C.

AU - Silver, Samuel M.

AU - Smith, Mary Lou

AU - Somlo, George

AU - Theriault, Richard L.

AU - Ward, John H.

AU - Winer, Eric P.

AU - Wolff, Antonio C.

PY - 2007/3/1

Y1 - 2007/3/1

N2 - The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician are responsible for jointly exploring and selecting the most appropriate option from among the available alternatives. With rare exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, not a single clinical situation exists in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient and physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment but also contribute to improving the treatment of future patients.

AB - The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician are responsible for jointly exploring and selecting the most appropriate option from among the available alternatives. With rare exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, not a single clinical situation exists in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient and physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment but also contribute to improving the treatment of future patients.

KW - Adjuvant therapy

KW - Breast cancer

KW - Breast-conserving therapy

KW - Chemotherapy

KW - Ductal carcinoma in situ

KW - Endocrine therapy

KW - Lobular carcinoma in situ

KW - Mastectomy

KW - NCCN Clinical Practice Guidelines

KW - Radiation

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=33947518806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947518806&partnerID=8YFLogxK

M3 - Review article

C2 - 17439758

AN - SCOPUS:33947518806

VL - 5

SP - 246

EP - 312

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 3

ER -